|
MX2010000944A
(es)
*
|
2007-07-26 |
2010-08-31 |
Amsterdam Molecular Therapeutics Bv |
Vectores baculovirales que comprenden secuencias de codificacion repetida con deformaciones diferenciales en codones.
|
|
GB0911870D0
(en)
|
2009-07-08 |
2009-08-19 |
Ucl Business Plc |
Optimised coding sequence and promoter
|
|
US9228174B2
(en)
*
|
2010-03-11 |
2016-01-05 |
Uniqure Ip B.V. |
Mutated rep encoding sequences for use in AAV production
|
|
WO2011122950A1
(en)
|
2010-04-01 |
2011-10-06 |
Amsterdam Molecular Therapeutics (Amt) Ip B.V. |
Monomeric duplex aav vectors
|
|
IT1400425B1
(it)
|
2010-06-08 |
2013-05-31 |
Amsterdam Molecular Therapeutics Bv |
Modified snrnas for use in therapy.
|
|
US20140155469A1
(en)
|
2011-04-19 |
2014-06-05 |
The Research Foundation Of State University Of New York |
Adeno-associated-virus rep sequences, vectors and viruses
|
|
GB201210357D0
(en)
|
2012-06-12 |
2012-07-25 |
Ucl Business Plc |
Factor VIII sequences
|
|
EP3060669B1
(en)
|
2013-10-24 |
2024-12-11 |
uniQure IP B.V. |
Aav-5 pseudotyped vector for gene therapy for neurological diseases
|
|
WO2015137802A1
(en)
|
2014-03-10 |
2015-09-17 |
Uniqure Ip B.V. |
Further improved aav vectors produced in insect cells
|
|
EP3151866B1
(en)
|
2014-06-09 |
2023-03-08 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
|
SG10202007103TA
(en)
|
2014-11-05 |
2020-09-29 |
Voyager Therapeutics Inc |
Aadc polynucleotides for the treatment of parkinson's disease
|
|
GB201420139D0
(en)
|
2014-11-12 |
2014-12-24 |
Ucl Business Plc |
Factor IX gene therapy
|
|
MX2017006216A
(es)
|
2014-11-14 |
2018-08-29 |
Voyager Therapeutics Inc |
Composiciones y métodos para tratar la esclerosis lateral amiotrófica (ela).
|
|
IL284949B2
(en)
|
2014-11-14 |
2024-06-01 |
Voyager Therapeutics Inc |
Modulatory polynucleotides
|
|
JP6741345B2
(ja)
|
2014-11-28 |
2020-08-19 |
ユニキュアー アイピー ビー．ブイ． |
パルボウイルスビリオンを含む組成物におけるｄｎａ不純物
|
|
WO2016094783A1
(en)
|
2014-12-12 |
2016-06-16 |
Voyager Therapeutics, Inc. |
Compositions and methods for the production of scaav
|
|
HRP20190992T1
(hr)
|
2014-12-24 |
2019-09-20 |
Uniqure Ip B.V. |
Suprimiranje gena za huntingtin inducirano s rnai
|
|
AU2017254652B2
(en)
*
|
2016-04-21 |
2022-12-01 |
Virovek, Inc. |
AAV production in insect cells, methods and compositions therefor
|
|
EP3448874A4
(en)
|
2016-04-29 |
2020-04-22 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
US11299751B2
(en)
|
2016-04-29 |
2022-04-12 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
|
EP3458588B1
(en)
|
2016-05-18 |
2025-10-29 |
Voyager Therapeutics, Inc. |
Modulatory polynucleotides
|
|
AU2017268382B2
(en)
|
2016-05-18 |
2023-09-28 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating Huntington's disease
|
|
IL305149A
(en)
*
|
2016-07-26 |
2023-10-01 |
Biomarin Pharm Inc |
Novel adeno-associated virus capsid proteins
|
|
WO2018039375A1
(en)
|
2016-08-23 |
2018-03-01 |
Akouos, Inc. |
Compositions and methods for treating non-age-associated hearing impairment in a human subject
|
|
US11298041B2
(en)
|
2016-08-30 |
2022-04-12 |
The Regents Of The University Of California |
Methods for biomedical targeting and delivery and devices and systems for practicing the same
|
|
EP3554579A1
(en)
|
2016-12-16 |
2019-10-23 |
uniQure IP B.V. |
Immunoadsorption
|
|
EP3618839A4
(en)
|
2017-05-05 |
2021-06-09 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating amyotrophic lateral sclerosis (als)
|
|
CN111108198A
(zh)
|
2017-05-05 |
2020-05-05 |
沃雅戈治疗公司 |
治疗亨廷顿病的组合物和方法
|
|
JOP20190269A1
(ar)
|
2017-06-15 |
2019-11-20 |
Voyager Therapeutics Inc |
بولي نوكليوتيدات aadc لعلاج مرض باركنسون
|
|
DK3652326T3
(da)
|
2017-07-10 |
2024-10-28 |
Uniqure Ip Bv |
Midler og fremgangsmåder til AAV-genterapi i mennesker
|
|
AU2018302016A1
(en)
|
2017-07-17 |
2020-02-06 |
The Regents Of The University Of California |
Trajectory array guide system
|
|
TWI832036B
(zh)
|
2017-08-03 |
2024-02-11 |
美商航海家醫療公司 |
用於aav之遞送之組合物及方法
|
|
EP3687582A4
(en)
|
2017-09-29 |
2021-07-14 |
Voyager Therapeutics, Inc. |
RESCUE OF CENTRAL AND PERIPHERAL NEUROLOGICAL PHENOTYPE OF FRIEDREICH ATAXIA BY INTRAVENOUS ADMINISTRATION
|
|
WO2019079242A1
(en)
|
2017-10-16 |
2019-04-25 |
Voyager Therapeutics, Inc. |
TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
|
|
CN111479924B
(zh)
|
2017-10-16 |
2024-06-14 |
沃雅戈治疗公司 |
肌萎缩性侧索硬化症(als)的治疗
|
|
CN111527201A
(zh)
|
2017-12-29 |
2020-08-11 |
优尼科Ip有限公司 |
修饰的病毒载体及其制备和使用方法
|
|
JP7389040B2
(ja)
|
2018-01-17 |
2023-11-29 |
メイラジーティーエックス・ユーケー・ザ・セカンド・リミテッド |
遺伝子治療のための修飾ｒＡＡＶキャプシドタンパク質
|
|
GB201800903D0
(en)
|
2018-01-19 |
2018-03-07 |
Oxford Genetics Ltd |
Vectors
|
|
MA52631A
(fr)
|
2018-05-15 |
2021-03-24 |
Voyager Therapeutics Inc |
Compositions et méthodes pour le traitement de la maladie de parkinson
|
|
TW202015742A
(zh)
|
2018-05-15 |
2020-05-01 |
美商航海家醫療公司 |
投遞腺相關病毒（ａａｖ）之組成物和方法
|
|
WO2019241486A1
(en)
|
2018-06-13 |
2019-12-19 |
Voyager Therapeutics, Inc. |
Engineered 5' untranslated regions (5' utr) for aav production
|
|
CA3103963A1
(en)
|
2018-07-02 |
2020-01-09 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord
|
|
JP2021530548A
(ja)
|
2018-07-24 |
2021-11-11 |
ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics, Inc. |
遺伝子治療製剤を生産するための系および方法
|
|
US10842885B2
(en)
|
2018-08-20 |
2020-11-24 |
Ucl Business Ltd |
Factor IX encoding nucleotides
|
|
GB201813528D0
(en)
|
2018-08-20 |
2018-10-03 |
Ucl Business Plc |
Factor IX encoding nucleotides
|
|
WO2020053258A1
(en)
|
2018-09-12 |
2020-03-19 |
Uniqure Ip B.V. |
Rnai induced c9orf72 suppression for the treatment of als/ftd
|
|
US20220125073A1
(en)
*
|
2018-09-20 |
2022-04-28 |
Tallgrass Biologics L.L.C. |
Treatment and control of colony collapse disorder
|
|
CN109295172A
(zh)
*
|
2018-09-26 |
2019-02-01 |
浙江海洋大学 |
大黄鱼清道夫受体家族基因的密码子偏好性分析方法
|
|
JP7528066B2
(ja)
|
2018-09-28 |
2024-08-05 |
ボイジャー セラピューティクス インコーポレイテッド |
操作されたプロモータを有するフラタキシン発現コンストラクトおよびその使用方法
|
|
EP3861113A1
(en)
|
2018-10-04 |
2021-08-11 |
Voyager Therapeutics, Inc. |
Methods for measuring the titer and potency of viral vector particles
|
|
CA3115248A1
(en)
|
2018-10-05 |
2020-04-09 |
Voyager Therapeutics, Inc. |
Engineered nucleic acid constructs encoding aav production proteins
|
|
WO2020077165A1
(en)
|
2018-10-12 |
2020-04-16 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
|
TW202028468A
(zh)
|
2018-10-15 |
2020-08-01 |
美商航海家醫療公司 |
用於桿狀病毒/Sf9系統中rAAV之大規模生產的表現載體
|
|
WO2020104295A1
(en)
|
2018-11-19 |
2020-05-28 |
Uniqure Ip B.V. |
Rnai induced reduction of ataxin-3 for the treatment of spinocerebellar ataxia type 3
|
|
WO2020104480A1
(en)
|
2018-11-19 |
2020-05-28 |
Uniqure Biopharma B.V. |
Adeno-associated virus vectors for expressing fviii mimetics and uses thereof
|
|
WO2020104469A1
(en)
|
2018-11-19 |
2020-05-28 |
Uniqure Ip B.V. |
Method and means to deliver mirna to target cells
|
|
CA3119721A1
(en)
|
2018-11-19 |
2020-05-28 |
Uniqure Ip B.V. |
A companion diagnostic to monitor the effects of gene therapy
|
|
SG11202107645RA
(en)
|
2019-01-18 |
2021-08-30 |
Voyager Therapeutics Inc |
Methods and systems for producing aav particles
|
|
WO2020223274A1
(en)
|
2019-04-29 |
2020-11-05 |
Voyager Therapeutics, Inc. |
SYSTEMS AND METHODS FOR PRODUCING BACULOVIRAL INFECTED INSECT CELLS (BIICs) IN BIOREACTORS
|
|
HUE069369T2
(hu)
|
2019-07-15 |
2025-02-28 |
Meiragtx Uk Ii Ltd |
Módosított AAV tokfehérjék ízületi gyulladásos betegségek kezelésére
|
|
WO2021030125A1
(en)
|
2019-08-09 |
2021-02-18 |
Voyager Therapeutics, Inc. |
Cell culture medium for use in producing gene therapy products in bioreactors
|
|
WO2021041375A1
(en)
*
|
2019-08-26 |
2021-03-04 |
Rootpath Genomics, Inc. |
Compositions and methods for producing adeno-associated viral vectors
|
|
WO2021041485A1
(en)
|
2019-08-26 |
2021-03-04 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
WO2021053018A1
(en)
|
2019-09-16 |
2021-03-25 |
Uniqure Ip B.V. |
Targeting misspliced transcripts in genetic disorders
|
|
IL293397A
(en)
*
|
2019-12-04 |
2022-07-01 |
Sangamo Therapeutics Inc |
New preparations and methods for the production of recombinant aav
|
|
MX2022010050A
(es)
|
2020-02-21 |
2022-09-05 |
Akouos Inc |
Composiciones y metodos para tratar deficiencia auditiva no asociada con la edad en un sujeto humano.
|
|
WO2021195491A2
(en)
*
|
2020-03-26 |
2021-09-30 |
Asklepios Biopharmaceutical, Inc. |
Inducible promoter for viral vector production
|
|
WO2021198508A1
(en)
|
2020-04-02 |
2021-10-07 |
Uniqure Biopharma B.V. |
Dual bifunctional vectors for aav production
|
|
EP4127146A1
(en)
|
2020-04-02 |
2023-02-08 |
uniQure biopharma B.V. |
Novel cell line
|
|
CA3174872A1
(en)
|
2020-04-07 |
2021-10-14 |
Sander Jan Hendrik Van Deventer |
Gene constructs for silencing angiopoietin-like 3 (angptl3) and uses thereof
|
|
AU2021257848A1
(en)
|
2020-04-15 |
2022-12-01 |
Voyager Therapeutics, Inc. |
Tau binding compounds
|
|
WO2022026410A2
(en)
|
2020-07-27 |
2022-02-03 |
Voyager Therapeutics, Inc |
Compositions and methods for the treatment of niemann-pick type c1 disease
|
|
MX2023000815A
(es)
|
2020-07-27 |
2023-04-11 |
Voyager Therapeutics Inc |
Composiciones y metodos para el tratamiento de trastornos neurologicos relacionados con la deficiencia de glucosilceramidasa beta.
|
|
EP4192514A1
(en)
|
2020-08-06 |
2023-06-14 |
Voyager Therapeutics, Inc. |
Cell culture medium for use in producing gene therapy products in bioreactors
|
|
EP4301768A2
(en)
|
2021-03-03 |
2024-01-10 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
US20240141378A1
(en)
|
2021-03-03 |
2024-05-02 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
WO2022188797A1
(en)
|
2021-03-09 |
2022-09-15 |
Huigene Therapeutics Co., Ltd. |
Engineered crispr/cas13 system and uses thereof
|
|
WO2022214635A1
(en)
|
2021-04-08 |
2022-10-13 |
Stichting Vu |
Nucleic acid molecules for compensation of stxbp1 haploinsufficiency and their use in the treatment of stxbp1-related disorders
|
|
WO2022253974A1
(en)
|
2021-06-02 |
2022-12-08 |
Uniqure Biopharma B.V. |
Adeno-associated virus vectors modified to bind high-density lipoprotein
|
|
EP4347798A2
(en)
|
2021-06-02 |
2024-04-10 |
uniQure biopharma B.V. |
Insect cell production of parvoviral vectors with modified capsid proteins
|
|
WO2022268811A1
(en)
|
2021-06-21 |
2022-12-29 |
Uniqure Biopharma B.V. |
Improved lysis procedures
|
|
JP2024523445A
(ja)
|
2021-06-21 |
2024-06-28 |
ユニキュアー バイオファーマ ビー．ブイ． |
α－シヌクレインをサイレンシングするための遺伝子構築物及びその使用
|
|
WO2023283962A1
(en)
|
2021-07-16 |
2023-01-19 |
Huigene Therapeutics Co., Ltd. |
Modified aav capsid for gene therapy and methods thereof
|
|
CA3227296A1
(en)
*
|
2021-07-28 |
2023-02-02 |
Tomas Cinek |
Large scale adeno-associated virus production systems
|
|
EP4392434A1
(en)
|
2021-08-26 |
2024-07-03 |
uniQure biopharma B.V. |
Insect cell-produced high potency aav vectors with cns-tropism
|
|
US20250049955A1
(en)
|
2021-11-17 |
2025-02-13 |
Voyager Therapeutics, Inc. |
Compositons and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiency
|
|
US20250346920A1
(en)
|
2022-01-25 |
2025-11-13 |
Voyager Therapeutics, Inc. |
Baculovirus expression system
|
|
CN114703203B
(zh)
*
|
2022-02-11 |
2024-08-06 |
上海渤因生物科技有限公司 |
杆状病毒载体及其用途
|
|
EP4508215A1
(en)
|
2022-04-12 |
2025-02-19 |
uniQure biopharma B.V. |
Novel systems for nucleic acid regulation
|
|
JP2025512061A
(ja)
|
2022-04-12 |
2025-04-16 |
ユニキュアー バイオファーマ ビー．ブイ． |
Ｓｎｃａの核酸調節
|
|
JP2025513066A
(ja)
|
2022-04-12 |
2025-04-22 |
ユニキュアー バイオファーマ ビー．ブイ． |
Ａｐｏｅの核酸制御
|
|
EP4508214A1
(en)
|
2022-04-12 |
2025-02-19 |
uniQure biopharma B.V. |
Nucleic acid regulation of c9orf72
|
|
WO2023240236A1
(en)
|
2022-06-10 |
2023-12-14 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of spinal muscular atrophy related disorders
|
|
WO2024054983A1
(en)
|
2022-09-08 |
2024-03-14 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
WO2024143440A1
(ja)
|
2022-12-28 |
2024-07-04 |
富士フイルム株式会社 |
アデノ随伴ウイルスの製造方法、およびベクターのセット
|
|
WO2024163012A1
(en)
|
2023-02-02 |
2024-08-08 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiency
|
|
AU2024258816A1
(en)
|
2023-04-18 |
2025-10-23 |
Uniqure Biopharma B.V. |
Generation of adeno-associated virus capsid libraries for insect cells
|
|
WO2024218192A1
(en)
|
2023-04-18 |
2024-10-24 |
Uniqure Biopharma B.V. |
Novel neurotropic adeno-associated virus capsids with detargeting of peripheral organs
|
|
WO2024218204A1
(en)
|
2023-04-18 |
2024-10-24 |
Uniqure Biopharma B.V. |
Gene delivery vehicles comprising rna and antibodies
|
|
WO2024226761A2
(en)
|
2023-04-26 |
2024-10-31 |
Voyager Therapeutics, Inc. |
Compositions and methods for treating amyotrophic lateral sclerosis
|
|
WO2024261220A1
(en)
|
2023-06-23 |
2024-12-26 |
Uniqure Biopharma B.V. |
Novel fragile x constructs
|
|
WO2025049993A1
(en)
|
2023-08-31 |
2025-03-06 |
Dyno Therapeutics, Inc. |
Capsid polypeptides and methods of use thereof
|
|
WO2025051805A1
(en)
|
2023-09-04 |
2025-03-13 |
Uniqure Biopharma B.V. |
Novel neurotropic recombinant adeno-associated virus particles
|
|
WO2025078598A1
(en)
|
2023-10-11 |
2025-04-17 |
Uniqure Biopharma B.V. |
Novel nucleic acid regulation of huntingtin gene
|
|
WO2025078602A1
(en)
|
2023-10-11 |
2025-04-17 |
Uniqure Biopharma B.V. |
Nucleic acid regulation of msh3 in repeat expansion disorders
|
|
WO2025078606A1
(en)
|
2023-10-11 |
2025-04-17 |
Uniqure Biopharma B.V. |
Further novel systems for nucleic acid regulation
|
|
WO2025114524A1
(en)
|
2023-11-30 |
2025-06-05 |
Uniqure Biopharma B.V. |
Formulations for viral drug products
|
|
WO2025171227A1
(en)
|
2024-02-08 |
2025-08-14 |
Dyno Therapeutics, Inc. |
Capsid polypeptides and methods of use thereof
|
|
WO2025219443A1
(en)
|
2024-04-19 |
2025-10-23 |
Uniqure Biopharma B.V. |
Nucleic acid for a1at regulation
|